| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $155K | +453.6% |
| R&D Expense | $7.1M | +22.8% |
| SG&A Expense | $4.5M | -33.5% |
| Operating Income | -$11.6M | +7.5% |
| Pre-tax Income | -$11.9M | +27.9% |
| Income Tax | $3K | -70.0% |
| Net Income | -$11.9M | +27.9% |
| EPS (Basic) | $8.96 | -66.0% |
| EPS (Diluted) | $8.96 | -66.0% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $6.0M | +404.7% |
| Current Assets | $6.6M | +195.0% |
| Total Assets | $7.2M | +152.0% |
| Current Liabilities | $2.8M | -21.7% |
| Total Liabilities | $4.6M | -32.7% |
| Stockholders' Equity | $2.6M | +165.3% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$10.8M | -28.9% |
| Capital Expenditures | $9K | -59.1% |
| Investing Cash Flow | -$14K | +36.4% |
| Financing Cash Flow | $15.6M | +206.4% |
| Free Cash Flow | -$10.8M | -28.6% |